1. Academic Validation
  2. Therapeutic effects and potential mechanism of dehydroevodiamine on N-methyl-N'-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis

Therapeutic effects and potential mechanism of dehydroevodiamine on N-methyl-N'-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis

  • Phytomedicine. 2021 Oct:91:153619. doi: 10.1016/j.phymed.2021.153619.
Jian-Xia Wen 1 Yu-Ling Tong 1 Xiao Ma 2 Rui-Lin Wang 3 Rui-Sheng Li 4 Hong-Tao Song 5 Yan-Ling Zhao 6
Affiliations

Affiliations

  • 1 Department of Pharmacy, Chinese PLA General Hospital, Beijing, China.
  • 2 School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • 3 Department of Integrative Medical Center, Chinese PLA General Hospital, Beijing, China.
  • 4 Research Center for Clinical and Translational Medicine, Chinese PLA General Hospital, Beijing, China.
  • 5 Department of Pharmacy, 900 Hospital of the Joint Logistics Team, Fuzhou, China. Electronic address: [email protected].
  • 6 Department of Pharmacy, Chinese PLA General Hospital, Beijing, China. Electronic address: [email protected].
Abstract

Backgrounds: Dehydroevodiamine (DHE) is a quinazoline alkaloid isolated from a Chinese herbal medicine, named Euodiae Fructus (Wu-Zhu-Yu in Chinese). This study aimed to investigate the therapeutic effects and potential mechanism of DHE on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced chronic atrophic gastritis (CAG) based on integrated approaches.

Methods: Therapeutic effects of DHE on serum biochemical indices and histopathology of gastric tissue in MNNG-induced CAG rats were analyzed. MNNG-induced GES-1 human gastric epithelial cell injury model was established. Cell viability and proliferation was quantified by a cell counting kit-8 assay. Cell morphology and mitochondrial membrane potential (MMP) were detected by a high content screening (HCS) assay. Cell migration and invasion were detected by a Transwell chamber. Moreover, UHPLC-Q-TOF/MS was performed to investigate the potential metabolites and signaling pathway affecting the protective effects of DHE on MNNG-induced cell migration and invasion of GES-1. Furthermore, in view of the key role of angiogenesis in the transformation of inflammation and Cancer, this study explored relative mRNA and protein expression levels of HIF-1α-mediated VEGF pathway in vivo and in vitro by RT-PCR and Western Blotting, respectively.

Results: The results showed that the therapeutic effects of DHE on CAG rats were presented in down-regulation serum biochemical indices and alleviating histological damage of gastric tissue. Besides, DHE has an effect on increasing cell proliferation of GES-1 cells, ameliorating MNNG-induced gastric epithelial cell damage and mitochondrial dysfunction. In addition, DHE could inhibit MNNG induced migration and invasion of GES-1 cells. Cell metabolomics analyses showed that the protective effect of DHE on GES-1 cells is mainly associated with the regulation of inflammation metabolites and energy metabolism related pathways. It was found that DHE has a regulating effect on tumor angiogenesis and can inhibit the relative gene and protein expression of HIF-1α-mediated VEGF signaling pathway.

Conclusions: The present work highlighted the role of DHE ameliorated gastric injury in MNNG-induced CAG rats in vivo and GES-1 cell migration in vitro by inhibiting HIF-1α/VEGF angiogenesis pathway. These results suggest that DHE may be the effective components of Euodiae Fructus, which provides a new agent for the treatment of CAG.

Keywords

Chronic atrophic gastritis; Dehydroevodiamine; Evodia fructus; HIF-1α/VEGF signaling pathway; N-methyl-N'-nitro-N-nitrosoguanidine.

Figures
Products